Wall Street is positive on Acutus Medical Inc (AFIB). On average, analysts give AFIB a Hold rating. The average price target is $2.25, which means analysts expect the stock to rise by 48.03% over the next twelve months. That average ranking earns AFIB an Analyst Rating of 5, which is better than 5% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating AFIB a Hold today. Find out what this means to you and get the rest of the rankings on AFIB!